Group B strep postpartum refers to infections caused by Streptococcus agalactiae that develop in women within the first six weeks after childbirth. These infections occur when the bacteria, which commonly colonize the rectum or vagina, invade tissues or enter the bloodstream during or shortly after delivery.
GBS is a common bacterium found in about 25% of healthy adults, particularly in the gastrointestinal and genitourinary tracts. While many carriers remain asymptomatic, the organism poses significant risk during labor and delivery. Postpartum GBS infections arise when the mother's immune system is weakened by childbirth stress, allowing the bacteria to cause invasive illness such as urinary tract infections, wound infections, sepsis, or endometritis.
The Centers for Disease Control and Prevention (CDC) recommends routine screening for GBS at 36 weeks of gestation. If a woman tests positive, administering intravenous penicillin during labor reduces the risk of transmission to the newborn by approximately 80%. However, postpartum infections still occur in 1-2% of colonized women who do not receive antibiotics or whose labor begins before screening.
After delivery, the mother's body undergoes rapid physiological changes. The cervix closes, the uterus contracts, and the placental site heals. This creates temporary breaches in tissue barriers. If GBS bacteria ascend from the birth canal into the uterus or enter through surgical incisions, they can trigger localized or systemic inflammation.
Common entry points include episiotomy sites, cesarean section wounds, or the cervix if membranes were ruptured early. Once inside, GBS produces toxins and enzymes that degrade host tissues and evade immune detection. The resulting infection may manifest as fever, chills, pelvic pain, foul-smelling vaginal discharge, or delayed wound healing.
A 2021 study published in *Clinical Infectious Diseases* found that 14% of postpartum GBS cases presented with fever above 38°C (100.4°F) within 24 hours of delivery, even when the mother had received antibiotics. This suggests that antibiotic prophylaxis prevents neonatal transmission but does not eliminate maternal risk entirely.
GBS postpartum infections fall into several categories based on location and severity:
| Type | Incidence Rate | Key Symptoms | Diagnosis Method |
|---|---|---|---|
| Endometritis | 1.5-3% | Fever, uterine tenderness, purulent lochia | Culture from uterine lining or blood |
| Wound infection (cesarean or episiotomy) | 2-5% | Pain, redness, swelling, pus at incision site | Visual exam + swab culture |
| Bacteremia/sepsis | 0.3-0.5% | High fever, confusion, low blood pressure | Blood cultures, CRP levels |
| Urinary tract infection (UTI) | 4-6% | Dysuria, frequency, suprapubic pain | Urine dipstick + culture |
Endometritis is the most frequent form, occurring in roughly 2% of vaginal deliveries and up to 5% after cesarean sections. It typically develops between 24 and 72 hours postpartum. A 2019 review in *The American Journal of Obstetrics & Gynecology* reported that 68% of endometritis cases diagnosed in the first week postpartum were due to GBS or mixed flora, including GBS.
One non-obvious fact: GBS can persist in the bladder even after a negative urine test if the sample is collected too soon after voiding. A follow-up urine culture taken 12 hours after urination increases detection accuracy by 30%, according to a 2020 study in *Journal of Clinical Microbiology*.
Many assume that GBS postpartum infections are rare or limited to high-risk pregnancies. In reality, they affect women regardless of age, parity, or preexisting conditions. GBS is not sexually transmitted-unlike gonorrhea or chlamydia-and does not require partner testing or treatment. The CDC explicitly states that GBS is not classified as a sexually transmitted disease (STD).
Is group b strep a std is a frequently asked question, but the answer remains clear: GBS colonization is not linked to sexual activity. It is part of normal human microbiota and spreads via fecal-oral or autoinoculation routes, not sexual contact.
Another misconception is that all postpartum fevers are due to GBS. In fact, postpartum fever occurs in 1-5% of deliveries, but only 10-15% of those cases involve GBS. Most are caused by other pathogens like Escherichia coli, Staphylococcus aureus, or viral agents. Misdiagnosing GBS as the sole cause delays proper treatment.
In 2022, a 32-year-old woman delivered vaginally at 39 weeks. She tested positive for GBS at 36 weeks but declined antibiotics due to a personal history of penicillin allergy. Her labor progressed normally, and she had no fever during delivery. On postpartum day 3, she developed a temperature of 38.8°C (101.8°F), severe lower abdominal pain, and foul-smelling lochia.
On examination, her uterus was tender and enlarged. Blood work showed elevated white blood cell count (16,000/µL) and C-reactive protein (CRP) of 120 mg/L. A vaginal swab grew GBS in pure culture. She was treated with IV ampicillin and gentamicin for five days. Her symptoms resolved within 72 hours, and she was discharged on oral cephalexin for two more days.
This case highlights that GBS can cause symptomatic infection even in women who deliver without fever or complications during labor. It also underscores the importance of antibiotic prophylaxis-even in asymptomatic carriers-to prevent both neonatal and maternal infections.
Prophylactic antibiotics during labor reduce maternal GBS infection rates by 70% compared to placebo, according to a 2023 Cochrane review. Penicillin G remains the first-line agent. For women with a confirmed penicillin allergy, alternatives include cefazolin or clindamycin, though resistance patterns vary by region.
Postpartum monitoring includes daily temperature checks, assessment of uterine fundal height, and evaluation of lochia for color, odor, and volume. Any fever above 38°C (100.4°F) within 48 hours of delivery warrants investigation for infection.
If GBS is suspected, cultures from blood, urine, or wound sites should be obtained before starting antibiotics. Empiric therapy should begin promptly while awaiting results. Delaying treatment increases the risk of sepsis and organ failure.
For women who have had a GBS-positive delivery, recurrence risk in subsequent pregnancies is approximately 30%. Re-screening at 36 weeks is recommended. If positive again, intrapartum antibiotics are advised unless contraindicated.
When managing postpartum GBS, clinicians must distinguish it from other causes of fever, such as mastitis or pulmonary embolism. A 2021 study in *Obstetrics & Gynecology* found that 22% of initial misdiagnoses involved confusing GBS endometritis with mastitis due to overlapping symptoms like fever and malaise.
Group B strep postpartum infections are preventable, treatable, and manageable with timely diagnosis and appropriate care. Awareness of symptoms, accurate screening, and adherence to guidelines reduce morbidity and mortality in the postpartum period.